ID

13118

Beschreibung

Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01133704

Link

https://clinicaltrials.gov/show/NCT01133704

Stichworte

  1. 17.01.16 17.01.16 -
Hochgeladen am

17. Januar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hormone-Refractory Prostate Cancer NCT01133704

Eligibility Hormone-Refractory Prostate Cancer NCT01133704

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically documented adenocarcinoma of the prostate
Beschreibung

prostate adenocarcinoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019638
UMLS CUI [1,2]
C0007112
metastatic disease as evidenced by soft tissue and/or bony metastases
Beschreibung

metastasis

Datentyp

boolean

Alias
UMLS CUI [1]
C0027627
prostate-specific antigen value of at least 5 ng/ml
Beschreibung

psa

Datentyp

boolean

Alias
UMLS CUI [1]
C0138741
tumor progression while on hormonal therapy
Beschreibung

tumor progression while on hormone therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0178874
UMLS CUI [1,2]
C0279025
castration levels of testosterone (defined as less than 50 ng/dl)
Beschreibung

testosterone

Datentyp

boolean

Alias
UMLS CUI [1]
C0523912
life expectancy of at least 16 weeks
Beschreibung

life expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
adequate hematologic, renal, and liver function
Beschreibung

organ function

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C0005953
UMLS CUI [1,3]
C0232804
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
visceral organ metastases
Beschreibung

visceral metastases

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0442045
metastatic disease expected to be in need of radiation therapy within 4 months.
Beschreibung

radiation therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C1522449
concurrent therapy with experimental agents
Beschreibung

study subject participation status, concurrent therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0009429

Ähnliche Modelle

Eligibility Hormone-Refractory Prostate Cancer NCT01133704

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
prostate adenocarcinoma
Item
histologically documented adenocarcinoma of the prostate
boolean
C0019638 (UMLS CUI [1,1])
C0007112 (UMLS CUI [1,2])
metastasis
Item
metastatic disease as evidenced by soft tissue and/or bony metastases
boolean
C0027627 (UMLS CUI [1])
psa
Item
prostate-specific antigen value of at least 5 ng/ml
boolean
C0138741 (UMLS CUI [1])
tumor progression while on hormone therapy
Item
tumor progression while on hormonal therapy
boolean
C0178874 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
testosterone
Item
castration levels of testosterone (defined as less than 50 ng/dl)
boolean
C0523912 (UMLS CUI [1])
life expectancy
Item
life expectancy of at least 16 weeks
boolean
C0023671 (UMLS CUI [1])
organ function
Item
adequate hematologic, renal, and liver function
boolean
C0232741 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
visceral metastases
Item
visceral organ metastases
boolean
C0027627 (UMLS CUI [1,1])
C0442045 (UMLS CUI [1,2])
radiation therapy
Item
metastatic disease expected to be in need of radiation therapy within 4 months.
boolean
C1522449 (UMLS CUI [1])
study subject participation status, concurrent therapy
Item
concurrent therapy with experimental agents
boolean
C2348568 (UMLS CUI [1])
C0009429 (UMLS CUI [2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video